AAAAAA

   
Results: 1-20 |
Results: 20
Vaccines for the prevention of HIV-1 disease
Authors: Mascola, JR Nabel, GJ
Citation: Jr. Mascola et Gj. Nabel, Vaccines for the prevention of HIV-1 disease, CURR OP IM, 13(4), 2001, pp. 489-495
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection
Authors: Kim, JH Mascola, JR Ratto-Kim, S VanCott, TC Loomis-Price, L Cox, JH Michael, NL Jagodzinski, L Hawkes, C Mayers, D Gilliam, BL Birx, DC Robb, ML
Citation: Jh. Kim et al., Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection, AIDS RES H, 17(11), 2001, pp. 1021-1034
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region
Authors: Barnet, SW Lu, S Srivastava, I Cherpelis, S Gettie, A Blanchard, J Wang, S Mboudjeka, I Leung, L Lian, Y Fong, A Buckner, C Ly, A Hilt, S Ulmer, J Wild, CT Mascola, JR Stamatatos, L
Citation: Sw. Barnet et al., The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region, J VIROLOGY, 75(12), 2001, pp. 5526-5540
Human skin Langerhans cells are targets of dengue virus infection
Authors: Wu, SJL Grouard-Vogel, G Sun, W Mascola, JR Brachtel, E Putvatana, R Louder, MK Filgueira, L Marovich, MA Wong, HK Blauvelt, A Murphy, GS Robb, ML Innes, BL Birx, DL Hayes, CG Frankel, SS
Citation: Sjl. Wu et al., Human skin Langerhans cells are targets of dengue virus infection, NAT MED, 6(7), 2000, pp. 816-820
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
Authors: Mascola, JR Stiegler, G VanCott, TC Katinger, H Carpenter, CB Hanson, CE Beary, H Hayes, D Frankel, SS Birx, DL Lewis, MG
Citation: Jr. Mascola et al., Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies, NAT MED, 6(2), 2000, pp. 207-210
Prevalence of genotypic and phenotypic resistance to anti-retroviral drugsin a cohort of therapy-naive HIV-1 infected US military personnel
Authors: Wegner, SA Brodine, SK Mascola, JR Tasker, SA Shaffer, RA Starkey, MJ Barile, A Martin, GJ Aronson, N Emmons, WW Stephan, K Bloor, S Vingerhoets, J Hertogs, K Larder, B
Citation: Sa. Wegner et al., Prevalence of genotypic and phenotypic resistance to anti-retroviral drugsin a cohort of therapy-naive HIV-1 infected US military personnel, AIDS, 14(8), 2000, pp. 1009-1015
A phase I/II trial of HIVSF2 gp120/MF59 vaccine in seronegative Thais
Authors: Nitayaphan, S Khamboonruang, C Sirisophana, N Morgan, P Chiu, J Duliege, AM Chuenchitra, C Supapongse, T Rungruengthanakit, K deSouza, M Mascola, JR Boggio, K Ratto-Kim, S Markowitz, LE Birx, D Suriyanon, V McNeil, JG Brown, AE Michael, RA
Citation: S. Nitayaphan et al., A phase I/II trial of HIVSF2 gp120/MF59 vaccine in seronegative Thais, VACCINE, 18(15), 2000, pp. 1448-1455
Immunologic strategies for herpes vaccination - Reply
Authors: Mascola, JR
Citation: Jr. Mascola, Immunologic strategies for herpes vaccination - Reply, J AM MED A, 283(6), 2000, pp. 747-747
Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRFO1_AE) generated by the polymerase chain reaction
Authors: Salminen, MO Ehrenberg, PK Mascola, JR Dayhoff, DE Merling, R Blake, B Louder, M Hegerich, S Polonis, VR Birx, DL Robb, ML McCutchan, FE Michael, NL
Citation: Mo. Salminen et al., Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRFO1_AE) generated by the polymerase chain reaction, VIROLOGY, 278(1), 2000, pp. 103-110
Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion
Authors: Ignatius, R Marovich, M Mehlhop, E Villamide, L Mahnke, K Cox, WI Isdell, F Frankel, SS Mascola, JR Steinman, RM Pope, M
Citation: R. Ignatius et al., Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion, J VIROLOGY, 74(23), 2000, pp. 11329-11338
Herpes simplex virus vaccines - Why don't antibodies protect?
Authors: Mascola, JR
Citation: Jr. Mascola, Herpes simplex virus vaccines - Why don't antibodies protect?, J AM MED A, 282(4), 1999, pp. 379-380
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
Authors: Michael, NL Herman, SA Kwok, S Dreyer, K Wang, J Christopherson, C Spadoro, JP Young, KKY Polonis, V McCutchan, FE Carr, J Mascola, JR Jagodzinsi, LL Robb, ML
Citation: Nl. Michael et al., Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes, J CLIN MICR, 37(8), 1999, pp. 2557-2563
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex
Authors: Wang, CY Sawyer, LSW Murthy, KK Fang, XD Walfield, AM Ye, J Wang, JJG Chen, PD Li, ML Salas, MT Shen, M Gauduin, MC Boyle, RW Koup, RA Montefiori, DC Mascola, JR Koff, WC Hanson, CV
Citation: Cy. Wang et al., Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex, P NAS US, 96(18), 1999, pp. 10367-10372
Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope
Authors: VanCott, TC Mascola, JR Loomis-Price, LD Sinangil, F Zitomersky, N McNeil, J Robb, ML Birx, DL Barnett, S
Citation: Tc. Vancott et al., Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope, J VIROLOGY, 73(6), 1999, pp. 4640-4650
Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
Authors: Mascola, JR Lewis, MG Stiegler, G Harris, D VanCott, TC Hayes, D Louder, MK Brown, CR Sapan, CV Frankel, SS Lu, YC Robb, ML Katinger, H Birx, DL
Citation: Jr. Mascola et al., Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies, J VIROLOGY, 73(5), 1999, pp. 4009-4018
Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion
Authors: Brodine, SK Shaffer, RA Starkey, MJ Tasker, SA Gilcrest, JL Louder, MK Barile, A VanCott, TC Vahey, MT McCutchan, FE Birx, DL Richman, DD Mascola, JR
Citation: Sk. Brodine et al., Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion, ANN INT MED, 131(7), 1999, pp. 502
Determination of syncytium-inducing phenotype of primary HIV-1 isolates using MT-2 cells
Authors: Louder, MK Mascola, JR
Citation: Mk. Louder et Jr. Mascola, Determination of syncytium-inducing phenotype of primary HIV-1 isolates using MT-2 cells, METH MOL M, 17, 1999, pp. 23-27
Determination of HIV-1 chemokine coreceptor tropism using transduced humanosteosarcoma (HOS) cells
Authors: Louder, MK Mascola, JR
Citation: Mk. Louder et Jr. Mascola, Determination of HIV-1 chemokine coreceptor tropism using transduced humanosteosarcoma (HOS) cells, METH MOL M, 17, 1999, pp. 29-33
Neutralization of HIV-1 infection of human peripheral blood mononuclear cells (PBMC) - Antibody dilution method
Authors: Mascola, JR
Citation: Jr. Mascola, Neutralization of HIV-1 infection of human peripheral blood mononuclear cells (PBMC) - Antibody dilution method, METH MOL M, 17, 1999, pp. 309-315
Neutralization of HIV-1 infection of human peripheral blood mononuclear cells (PBMC) - Infectivity reduction method
Authors: Mascola, JR
Citation: Jr. Mascola, Neutralization of HIV-1 infection of human peripheral blood mononuclear cells (PBMC) - Infectivity reduction method, METH MOL M, 17, 1999, pp. 317-322
Risultati: 1-20 |